Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Luke Wiseman

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 28, 2023
Optimization of 3-aminotetrahydrothiophene 1,1-dioxides with improved potency and efficacy as non-electrophilic antioxidant response element (ARE) activatorsJeyun Jo, Jisu Kim, Lara Ibrahim, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2025
Drug repurposing screen identifies an HRI activating compound that promotes adaptive mitochondrial remodeling in MFN2-deficient cellsPrerona Bora, Mashiat Zaman, Samantha Oviedo, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2012
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascadeChristine E Bulawa, Stephen Connelly, Michael Devit, et al.
ACS Chemical Biology|January 10, 2024
Covalent Targeting As a Common Mechanism for Inhibiting NLRP3 Inflammasome AssemblyCaroline Stanton, Jie Sun, Kayla Nutsch, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 24, 2018
A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeuticsRichard M Giadone, Jessica D Rosarda, Prithvi Reddy Akepati, et al.
Nature Chemical Biology|July 22, 2020
Pharmacologic IRE1/XBP1s activation confers targeted ER proteostasis reprogrammingJulia M D Grandjean, Aparajita Madhavan, Lauren Cech, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2023
S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signalingYeonjin Ko, Mannkyu Hong, Seungbeom Lee, et al.
Journal of Molecular and Cellular Cardiology|February 24, 2024
ATF6 protects against protein misfolding during cardiac hypertrophyChristoph Hofmann, Marjan Aghajani, Cecily D Alcock, et al.
Brain : a Journal of Neurology|February 20, 2025
Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1BThierry Touvier, Francesca A Veneri, Anke Claessens, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1BThierry Touvier, Francesca A Veneri, Anke Claessens, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry Letters|April 28, 2023
Optimization of 3-aminotetrahydrothiophene 1,1-dioxides with improved potency and efficacy as non-electrophilic antioxidant response element (ARE) activatorsJeyun Jo, Jisu Kim, Lara Ibrahim, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2025
Drug repurposing screen identifies an HRI activating compound that promotes adaptive mitochondrial remodeling in MFN2-deficient cellsPrerona Bora, Mashiat Zaman, Samantha Oviedo, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2012
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascadeChristine E Bulawa, Stephen Connelly, Michael Devit, et al.
ACS Chemical Biology|January 10, 2024
Covalent Targeting As a Common Mechanism for Inhibiting NLRP3 Inflammasome AssemblyCaroline Stanton, Jie Sun, Kayla Nutsch, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 24, 2018
A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeuticsRichard M Giadone, Jessica D Rosarda, Prithvi Reddy Akepati, et al.
Nature Chemical Biology|July 22, 2020
Pharmacologic IRE1/XBP1s activation confers targeted ER proteostasis reprogrammingJulia M D Grandjean, Aparajita Madhavan, Lauren Cech, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2023
S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signalingYeonjin Ko, Mannkyu Hong, Seungbeom Lee, et al.
Journal of Molecular and Cellular Cardiology|February 24, 2024
ATF6 protects against protein misfolding during cardiac hypertrophyChristoph Hofmann, Marjan Aghajani, Cecily D Alcock, et al.
Brain : a Journal of Neurology|February 20, 2025
Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1BThierry Touvier, Francesca A Veneri, Anke Claessens, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1BThierry Touvier, Francesca A Veneri, Anke Claessens, et al.
Pageof 13